Injection Site Pain
140 drugs269,579 FAERS reportsMedDRA PT
GET
/api/v1/reaction/injection-site-painReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Injection Site Pain (140)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Niobium1100%
- 2Tantalum1100%
- 3Zopapogene Imadenovec1100%
- 4Somatrogon77866%
- 5Motixafortide3337%
- 6Gozetotide13732%
- 7Gallium12830%
- 8Lenacapavir12430%
- 9Galcanezumab7,20724%
- 10Florbetaben424%
- 11Vitamin B6120%
- 12Sibeprenlimab1119%
- 13Clesrovimab218%
- 14Cobamamide114%
- 15Ferrous Cysteine Glycinate114%
- 16Magnesium Ascorbate114%
- 17Nadh114%
- 18Pyridoxal114%
- 19Threonate114%
- 20Zinc Ascorbate114%
- 21Asfotase Alfa1,27914%
- 22Fremanezumab1,28012%
- 23Dulaglutide9,87211%
- 24Zilucoplan7711%
- 25Ioflupane5911%
- 26Mirikizumab8111%
- 27Cabotegravir1,56411%
- 28Lebrikizumab14811%
- 29Ixekizumab3,86611%
- 30Donidalorsen1610%
- 31Aripiprazole Lauroxil4329.7%
- 32Concizumab39.7%
- 33Etanercept56,7019.6%
- 34Tirzepatide13,1779.4%
- 35Lonapegsomatropin488.7%
- 36Glatiramer5,3398.6%
- 37Tesamorelin1308.6%
- 38Setmelanotide228.4%
- 39Rilonacept767.9%
- 40Naltrexone3,1577.9%
- 41Balsalazide397.8%
- 42Pralidoxime27.7%
- 43Olezarsen317.6%
- 44Lanreotide5777.6%
- 45Dupilumab32,8577.5%
- 46Oxidronate107.5%
- 47Octreotide2,1877.2%
- 48Inclisiran5317.1%
- 49Degarelix3566.9%
- 50Calcium Citrate26.9%
- 51Adalimumab48,0546.7%
- 52Evolocumab10,5466.7%
- 53Pegvisomant2616.4%
- 54Interferon Beta-1b1,1996.3%
- 55Leuprolide4,8696.3%
- 56Florbetapir76.3%
- 57Plozasiran16.3%
- 58Anakinra1,0056.2%
- 59Bimekizumab9606.0%
- 60Collagenase Clostridium Histolyticum3215.9%
- 61Castor Oil105.6%
- 62Icatibant4765.6%
- 63Tralokinumab3085.6%
- 64Erenumab2,8485.3%
- 65Pegvaliase4145.2%
- 66Rilpivirine1,2665.2%
- 67Alirocumab1,2865.2%
- 68Somatropin3,6405.1%
- 69Mecasermin415.1%
- 70Procaine44.9%
- 71Lanadelumab1444.9%
- 72Garadacimab154.8%
- 73Collagenase3224.6%
- 74Caplacizumab724.4%
- 75Belimumab1,3354.3%
- 76Teriparatide4,8154.3%
- 77Pyrithione244.3%
- 78Romosozumab5364.2%
- 79Pimecrolimus674.2%
- 80Influenza A Virus1784.2%
- 81Vaborbactam24.1%
- 82Marstacimab23.9%
- 83Metreleptin483.9%
- 84Exenatide2,0233.9%
- 85Burosumab2373.9%
- 86Hyaluronidase3573.7%
- 87Tavaborole23.6%
- 88Tuberculin923.6%
- 89Acetate14,5253.5%
- 90Abaloparatide8613.4%
- 91Peginterferon Beta-1a4443.4%
- 92Elapegademase103.4%
- 93Indole513.4%
- 94Skatole513.4%
- 95Tartaric Acid513.4%
- 96Barium Iodide513.4%
- 97Skim Milk513.4%
- 98Pine Tar513.4%
- 99Hydrofluoric Acid513.3%
- 100Brodalumab643.3%
- 101Interferon Beta-1a6,3183.3%
- 102Diflunisal263.2%
- 103Pegcetacoplan543.2%
- 104Halcinonide63.1%
- 105Ofatumumab1,0083.1%
- 106Tezepelumab1713.0%
- 107Halobetasol432.9%
- 108Clobetasol3152.9%
- 109Phenol522.7%
- 110Articaine212.7%
- 111Ubrogepant1532.7%
- 112Eucalyptol512.7%
- 113Nabumetone1672.6%
- 114Insulin Glargine6,3892.6%
- 115Alprostadil922.6%
- 116Ganirelix162.6%
- 117Naratriptan342.5%
- 118Polidocanol342.5%
- 119Givosiran342.5%
- 120Hemin132.5%
- 121Sumatriptan1,0812.4%
- 122Somapacitan32.4%
- 123Insulin Detemir9052.3%
- 124Interferon Gamma-1b322.3%
- 125Norgestimate1022.3%
- 126Insulin Lispro3,0572.2%
- 127Lixisenatide762.2%
- 128Insulin Degludec5172.1%
- 129Palmitate6822.1%
- 130Triptorelin1202.1%
- 131Lumasiran72.0%
- 132Regadenoson952.0%
- 133Eletriptan1301.9%
- 134Bremelanotide161.8%
- 135Mercaptopurine3091.8%
- 136Liraglutide8611.7%
- 137Delgocitinib31.7%
- 138Technetium131.3%
- 139Emicizumab1461.3%
- 140Berotralstat25—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Injection Site Erythema34 shared · 0.23
- Injection Site Bruising27 shared · 0.19
- Injection Site Pruritus23 shared · 0.16
- Injection Site Swelling22 shared · 0.16
- Incorrect Dose Administered26 shared · 0.14
- Injection Site Mass18 shared · 0.13
- Injection Site Reaction18 shared · 0.12
- Inappropriate Schedule Of Product Administration27 shared · 0.11
- Product Dose Omission Issue57 shared · 0.11
- Pain In Extremity54 shared · 0.10
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.